Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
Esketamine (ESK) nasal spray, taken with oral antidepressant therapy, is approved for the treatment of depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavio...